Now out in @JCardFail by #HFC members @mvaduganathan, @scottdsolomon, Brian Claggett, John McMurray et al. This study assesses how sleep apnea impacts cardiac function, and outcomes in HFpEF, using data from the PARAGON-HF echocardiographic substudy. https://t.co/tAeaESDj2X

A novel 4-stage #POCUS protocol to estimate RAP by visual comparison of IJV and carotid artery sizes in #JACCHF. Test it out! #Stage4isHigh #DontMissTheHighOnes https://t.co/hTl8En32n5 @Deoliveiragdc @JTThibs @utswheart @UTSWInternalMed @CardioNerds @JACCJournals @NephroP @HFSA

Endlessly proud of our #HFC member @Deoliveiragdc 👏🏻👏🏻

📢 Time for one of our most anticipated meetings of the year! Novel Statistical Concepts for HF Drug and Device Development Join us on November 14, 2025 | 8:45 a.m - 12:30 p.m. ET via Zoom Open to all — no HFC membership required Register here: https://t.co/7O7YZP11zE

Out now in @escardio 📢 Led by @robmentz, @FudimMarat, @JavedButler1 et al, this consensus outlines a practical, evidence-based framework to standardize early in-hospital care for acute heart failure and improve outcomes. #HeartFailure #ExpertConsensus https://t.co/BSAgyowbI2

Out now: insights on pre-HF measures from #HFC member @vbluml et at. Adding preclinical HF measures (biomarkers + echo) to PREVENT-HF categories enhances risk identification and prediction Congratulations to the full team for moving the field forward 👏🏻 https://t.co/3qBMC26OtB

Have patients said to have recovered from CS really recovered? In @JCardFail, @vbluml argues against equating survival with recovery. Proposes a lexicon that distinguishes survival, remission, & recovery as discrete, clinically meaningful outcomes https://t.co/O70Taxc2qz

Proud to see #HFC leaders driving the conversation in #HFrEF treatment 👏🏻👏🏻 In this @ACCinTouch CardiaCast episode, @vbluml and @EMDeFilippisMD discuss the 2024 ACC Expert Consensus Pathway for HFrEF care.

🎧 ACC CardiaCast: 2024 ACC Expert Consensus Decision Pathway for Treatment of #HFrEF Get guidance on how to implement a structured multidisciplinary #HeartFailure approach that improves clinical & patient-centered outcomes. 🔗 https://t.co/5Y6ekxhRsc @vbluml

Now out in @CircHF by #HFC member @EMDeFilippisMD and colleagues. This study investigates the clinical implications of elevated donor-derived cell-free DNA (dd-cfDNA) levels in heart transplant recipients without biopsy-proven rejection. https://t.co/RfOpvexEah

Out of the press in @JCardFail 📢 Led by our #HFC member @FudimMarat, this analysis examines heart failure devices and introduces a practical mnemonic to help clinicians promptly identify patients for device therapy consideration. https://t.co/Vo0HHNl7pw

New Episode Alert 💙 Heart of The Matter: Cardio Pod is now live! Representation vs. Diversity in clinical trials—A key distinction for Equity Tune in now and join the conversation on this critical topic for clinical trials https://t.co/js76HHR1k2 #HF #Equity #ClinicalTrials

Fun time recording today with @AnkurKalraMD @dranulala & talking about the Prevention in #heartfailure #CVPrev #Parallax @HFSA @ASPCardio @JCardFail @AJPCardio

Very relevant issues discussed on podcast today but in a refreshing light light. Never get s old for me!!!

@ISHVnews

🎙️ Watch a sneak peek of our new cardiopod episode! Explore the importance of true representation in clinical trials — why it matters, how it’s achieved, and the impact on patient care. Full episode out now 👉 https://t.co/hnwOc3F8a0 #heartfailure #clinicaltrial #podcast

Last day of HFSA Scientific Sessions — and we couldn’t be prouder of our HFC members! What a successful year for the heart failure community and our team 💙 Check out the final day’s agenda, and congratulations to everyone involved in driving progress in heart failure care!

The role our members play in advancing the #HF field is nothing short of extraordinary! Congrats Dr. William Abraham

Great work @fudimmarat ! Proud of our members always moving the field forward!

Endlessly proud of our #HFC member @vbluml